182 related articles for article (PubMed ID: 28689966)
1. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations.
Münster M; Mohamed-Ahmed AHA; Immohr LI; Schoch C; Schmidt C; Tuleu C; Breitkreutz J
Int J Pharm; 2017 Aug; 529(1-2):310-318. PubMed ID: 28689966
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.
Maragos S; Archontaki H; Macheras P; Valsami G
AAPS PharmSciTech; 2009; 10(4):1444-51. PubMed ID: 19949903
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Praziquantel/Cyclodextrin Inclusion Complexation by NMR and LC-HRMS/MS: Mechanism, Solubility, Chemical Stability, and Degradation Products.
Špehar TK; Pocrnić M; Klarić D; Bertoša B; Čikoš A; Jug M; Padovan J; Dragojević S; Galić N
Mol Pharm; 2021 Nov; 18(11):4210-4223. PubMed ID: 34670371
[TBL] [Abstract][Full Text] [Related]
4. Multiparticulate system combining taste masking and immediate release properties for the aversive compound praziquantel.
Münster M; Schoch C; Schmidt C; Breitkreutz J
Eur J Pharm Sci; 2017 Nov; 109():446-454. PubMed ID: 28887230
[TBL] [Abstract][Full Text] [Related]
5. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
6. Host-guest kinetic interactions between HP-β-cyclodextrin and drugs for prediction of bitter taste masking.
Guo Z; Wu F; Singh V; Guo T; Ren X; Yin X; Shao Q; York P; Patterson LH; Zhang J
J Pharm Biomed Anal; 2017 Jun; 140():232-238. PubMed ID: 28365517
[TBL] [Abstract][Full Text] [Related]
7. Rational development of taste masked oral liquids guided by an electronic tongue.
Woertz K; Tissen C; Kleinebudde P; Breitkreutz J
Int J Pharm; 2010 Nov; 400(1-2):114-23. PubMed ID: 20816732
[TBL] [Abstract][Full Text] [Related]
8. Associated-Extraction Efficiency of Six Cyclodextrins on Various Flavonoids in Puerariae Lobatae Radix.
Feng T; Liu F; Sun L; Huo H; Ren X; Wang M
Molecules; 2018 Dec; 24(1):. PubMed ID: 30591701
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
10. Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.
Wei Y; Nedley MP; Bhaduri SB; Bredzinski X; Boddu SH
AAPS PharmSciTech; 2015 Apr; 16(2):455-65. PubMed ID: 25361901
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates.
Preis M; Grother L; Axe P; Breitkreutz J
Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M
J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding.
Cugovčan M; Jablan J; Lovrić J; Cinčić D; Galić N; Jug M
J Pharm Biomed Anal; 2017 Apr; 137():42-53. PubMed ID: 28092854
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
16. [Difference in inclusion behavior of β-cyclodextrin and hydroxypropyl-β-cyclodextrin with menthol].
Wan GW; Xie H; Mao CQ; Tang RQ; Yao C; Wang Z
Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(18):3336-3341. PubMed ID: 28925114
[TBL] [Abstract][Full Text] [Related]
17. Solid state characterisation and taste masking efficiency evaluation of polymer based extrudates of isoniazid for paediatric administration.
Keating AV; Soto J; Tuleu C; Forbes C; Zhao M; Craig DQM
Int J Pharm; 2018 Feb; 536(2):536-546. PubMed ID: 28687346
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives.
Wang H; Xie X; Zhang F; Zhou Q; Tao Q; Zou Y; Chen C; Zhou C; Yu S
Food Chem Toxicol; 2011 Jun; 49(6):1387-93. PubMed ID: 21426923
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
